Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.

Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.

Mortality due to COVID-19 is not increased in immunosuppressed individuals after liver transplantation (OLT) compared to individuals without immunosuppression. Data on long-term protective immunity against SARS-CoV-2 in immunosuppressed convalescents, is limited. We prospectively measured immune res...

Full description

Bibliographic Details
Main Authors: Theresa Kirchner, Sophia Heinrich, Agnes Bonifacius, Bastian Engel, Louisa Ruhl, Isabell Pink, Nele Thomas, Joerg Martens, Marius M Hoeper, Rainer Blasczyk, Heiner Wedemeyer, Elmar Jaeckel, Yang Li, Christine S Falk, Britta Eiz-Vesper, Richard Taubert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0276929

Internet

https://doi.org/10.1371/journal.pone.0276929

Similar Items